Webinar: Ask the expert with Professor Marcela Votruba
The latest webinar from Retina UK.
Search results
The latest webinar from Retina UK.
It has recently been announced that Meira-GTx, who originally developed bota-vec and collaborated with J&J during its early clinical trials, have entered into an asset purchase agreement with J&J to acquire bota-vec and progress the program towards global regulatory filings for approval.
When we talk about gene therapy we are usually referring to use of a harmless virus, called a vector, to deliver a normal copy of a defective gene into the cells of the eye.
Choroideremia is a rare genetic condition resulting in progressive sight loss in men.
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Are you affected by inherited sight loss? We are here to help.
Mark your special day, whilst fundraising for people with inherited sight loss.
We are proud to work collaboratively with a number of corporate partners to enable our community to live fulfilled lives today as well as supporting the pharmaceutical industry in their mission to develop potential new treatments.
Caryn talks about her experience taking part in the 2021 Virtual London Marathon.